• Citer

Drug repositioning for treatment-resistant depression: Hypotheses from a pharmacogenomic study

par Fabbri, Chiara;Kasper, Siegfried;Zohar, Joseph;Souery, Daniel ;Montgomery, Stuart;Albani, Diego;Forloni, GianLuigi Luigi G.;Ferentinos, Panagiotis;Rujescu, Dan;Mendlewicz, Julien ;De Ronchi, Diana;Riva, Marco Andrea;Lewis, Cathryn C.M.;Serretti, Alessandro
Référence Progress in neuro-psychopharmacology & biological psychiatry, 104, 110050
Publication Publié, 2021-01

Article révisé par les pairs

• Détails
• Contenu

Titre:	Drug repositioning for treatment-resistant depression: Hypotheses from a pharmacogenomic study
Auteur:	Fabbri, Chiara; Kasper, Siegfried; Zohar, Joseph; Souery, Daniel; Montgomery, Stuart; Albani, Diego; Forloni, GianLuigi Luigi G.; Ferentinos, Panagiotis; Rujescu, Dan; Mendlewicz, Julien; De Ronchi, Diana; Riva, Marco Andrea; Lewis, Cathryn C.M.; Serretti, Alessandro
Informations sur la publication:	Progress in neuro-psychopharmacology & biological psychiatry, 104, 110050
Statut de publication:	Publié, 2021-01
Sujet CREF:	Pharmacologie
	Physiopsychologie et psychologie biologique [psychiatrie]
Mots-clés:	Drug repurposing
	Major depression
	Pharmacogenetics
	Treatment-resistant depression
Note générale:	SCOPUS: ar.j
	DecretOANoAutActif
Langue:	Anglais
Identificateurs:	urn:issn:0278-5846
	info:doi/10.1016/j.pnpbp.2020.110050
	info:pii/S0278584620303663
	info:scp/85088973537
	info:pmid/32738352